The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: KSH01-TCRT Solid Tumors
Official Title: A Single-arm, Prospective Clinical Study of KSH01-TCR-T in the Treatment of Refractory/Recurrent Solid Tumors
Study ID: NCT05539833
Brief Summary: 1) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
The first affiliated hospital of Guang Xi medical university, Nanning, Guang XI, China
Name: Jie Ma
Affiliation: First Affiliated Hospital of Guangxi Medical University
Role: PRINCIPAL_INVESTIGATOR